An Adolescent with Undiagnosed Inattentive-Type Attention Deficit–Hyperactivity Disorder and Comorbid Migraine: A Case Report
Abstract
ABSTRACT Patients with attention deficit–hyperactivity disorder (ADHD) commonly exhibit symptoms such as difficulty paying attention and focusing, trouble controlling their behavior, and hyperactivity. Comorbidities frequently occur with ADHD, including a variety of psychiatric issues, medical conditions, and learning disorders. The lack of adequate pediatric mental health resources highlights the critical need for experienced nurses and NPs to play a pivotal role in diagnosing and treating ADHD, ensuring timely care for young patients. This article presents a case study of an adolescent with ADHD with inattention and migraine, but not hyperactivity or impulsivity. The patient was not diagnosed until adolescence, causing frustration for the patient and the family, and resulting in academic failure. An NP diagnosed the patient and treated him with the stimulant methylphenidate, which resulted in a positive academic outcome and improved quality of life. It is critical to identify, diagnose, and treat ADHD early and appropriately for optimal patient outcomes. This is especially true for adolescents with previously undiagnosed inattentive-type ADHD. This case report describes an adolescent with inattention and migraine who was not diagnosed with attention deficit–hyperactivity disorder until age 14, when the teen established care with an NP experienced in treating ADHD.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.